Nasdaq:US$13.45 (+0.81) | HKEX:HK$19.34 (-1.16) | AIM:£2.20 (+0.2)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

1 items
a070702